Shanghai Labway Clinical Laboratory Co Ltd
SZSE:301060
Shanghai Labway Clinical Laboratory Co Ltd
Cash from Financing Activities
Shanghai Labway Clinical Laboratory Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shanghai Labway Clinical Laboratory Co Ltd
SZSE:301060
|
Cash from Financing Activities
¥44.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Cash from Financing Activities
-¥7.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Cash from Financing Activities
-¥830.9m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Cash from Financing Activities
-¥2.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Cash from Financing Activities
-¥677.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
Huadong Medicine Co Ltd
SZSE:000963
|
Cash from Financing Activities
-¥472.5m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
See Also
What is Shanghai Labway Clinical Laboratory Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
44.7m
CNY
Based on the financial report for Dec 31, 2023, Shanghai Labway Clinical Laboratory Co Ltd's Cash from Financing Activities amounts to 44.7m CNY.
What is Shanghai Labway Clinical Laboratory Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-11%
Over the last year, the Cash from Financing Activities growth was -11%.